www.g4media.ro/compania-olandeza-heineken-ingrijor

Heineken has warned UK pubs and bars to adapt to the rising use of weight-loss drugs like GLP-1, which could impact beer sales. The company noted that users of these medications tend to drink less alcohol and prefer smaller portions. Heineken suggests promoting smaller beer servings and low-alcohol options to retain customers. The alcohol industry is already facing declining sales due to health-conscious consumer behavior. Other beverage producers have varying views on the impact of these drugs on sales, with some believing effects can be managed.